Sex specific EEG signatures associated with cerebrospinal fluid biomarkers in mild cognitive impairment. (October 2022)
- Record Type:
- Journal Article
- Title:
- Sex specific EEG signatures associated with cerebrospinal fluid biomarkers in mild cognitive impairment. (October 2022)
- Main Title:
- Sex specific EEG signatures associated with cerebrospinal fluid biomarkers in mild cognitive impairment
- Authors:
- Chino-Vilca, Brenda
Rodríguez-Rojo, Inmaculada Concepción
Torres-Simón, Lucía
Cuesta, Pablo
Vendrell, Anna Carnes
Piñol-Ripoll, Gerard
Huerto, Raquel
Tahan, Nuria
Maestú, Fernando - Abstract:
- Highlights: EEG spectral power is a non-invasive approach for tracking AD neuropathology. This study contributes to the validity of EEG-based biomarkers for the early diagnosis of AD. Results provide potential sex-related differences regarding the association between EEG-CSF parameters. Abstract: Objective: The use of the electroencephalography (EEG) technique in Alzheimer's disease (AD) diagnosis is scarce due to a lack of validation of its neurophysiological information with current biomarkers. Therefore, our goal was to assess correlations between brain spectral power signatures and cerebrospinal fluid markers (CSF) such as amyloid-β 42 load (Aβ-42), total tau (t-tau), and phosphorylated tau (p-tau) in a mild cognitive impairment (MCI) population. Furthermore, given the AD sex-dependent vulnerability related to CSF biomarkers, we went a little forward looking for different electrophysiological correlations for males and females independently. Methods: A data-driven approach was employed to determine bidimensional spectral power signatures (space-frequency) that correlated (Spearman) significantly with any of the three CSF markers in 27 patients with MCI in any of the two sex-dependent subsamples (i.e., 12 females and 15 males). Results: Our main significant outcomes evidenced 1) a negative correlation of Aβ-42 load with central-posterior theta power and a negative correlation of t-tau with widespread alpha power within the male subsample, and 2) a significant negativeHighlights: EEG spectral power is a non-invasive approach for tracking AD neuropathology. This study contributes to the validity of EEG-based biomarkers for the early diagnosis of AD. Results provide potential sex-related differences regarding the association between EEG-CSF parameters. Abstract: Objective: The use of the electroencephalography (EEG) technique in Alzheimer's disease (AD) diagnosis is scarce due to a lack of validation of its neurophysiological information with current biomarkers. Therefore, our goal was to assess correlations between brain spectral power signatures and cerebrospinal fluid markers (CSF) such as amyloid-β 42 load (Aβ-42), total tau (t-tau), and phosphorylated tau (p-tau) in a mild cognitive impairment (MCI) population. Furthermore, given the AD sex-dependent vulnerability related to CSF biomarkers, we went a little forward looking for different electrophysiological correlations for males and females independently. Methods: A data-driven approach was employed to determine bidimensional spectral power signatures (space-frequency) that correlated (Spearman) significantly with any of the three CSF markers in 27 patients with MCI in any of the two sex-dependent subsamples (i.e., 12 females and 15 males). Results: Our main significant outcomes evidenced 1) a negative correlation of Aβ-42 load with central-posterior theta power and a negative correlation of t-tau with widespread alpha power within the male subsample, and 2) a significant negative correlation between t-tau and widespread beta power in the female subgroup. Conclusions: There is a distinctive profile of correlations between resting-state electrophysiological signatures and CSF markers in male and female individuals. Significance: The combination of these two measures would be pointing out the need of a more personalized approach to promote early AD diagnosis. … (more)
- Is Part Of:
- Clinical neurophysiology. Volume 142(2022)
- Journal:
- Clinical neurophysiology
- Issue:
- Volume 142(2022)
- Issue Display:
- Volume 142, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 142
- Issue:
- 2022
- Issue Sort Value:
- 2022-0142-2022-0000
- Page Start:
- 190
- Page End:
- 198
- Publication Date:
- 2022-10
- Subjects:
- Mild cognitive impairment -- Cerebrospinal fluid -- Biomarkers electroencephalography -- Brain oscillations -- Neuropsychology
AD Alzheimer's Disease -- CSF Cerebrospinal fluid -- MCI Mild Cognitive Impairment -- AB Amyloid B -- MMSE Mini-Mental State Examination -- MRI Magnetic resonance imaging -- EEG Electroencephalogram -- FDG-PET 18F-fluorodeoxyglucose positron emission tomography
Neurophysiology -- Periodicals
Electroencephalography -- Periodicals
Electromyography -- Periodicals
Neurology -- Periodicals
612.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13882457 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.clinph.2022.08.007 ↗
- Languages:
- English
- ISSNs:
- 1388-2457
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.310645
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23875.xml